Edenred Valuation
Is EDENP undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of EDENP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: EDENP (€28.7) is trading below our estimate of fair value (€40.25)
Significantly Below Fair Value: EDENP is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EDENP?
Key metric: As EDENP is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is EDENP's PE Ratio? | |
|---|---|
| PE Ratio | 23.2x |
| Earnings | €300.00m |
| Market Cap | €6.95b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 3.6x |
| Enterprise Value/EBITDA | 12.7x |
| PEG Ratio | 1.4x |
Price to Earnings Ratio vs Peers
How does EDENP's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 38.7x | ||
WISE Wise | 19.9x | -7.9% | UK£8.6b |
BOKU Boku | 96.6x | 38.6% | UK£553.1m |
PAY PayPoint | 16.9x | n/a | UK£602.4m |
FNX Fonix | 21.6x | 2.2% | UK£229.6m |
EDENP Edenred | 23.2x | 16.3% | €7.0b |
Price-To-Earnings vs Peers: EDENP is good value based on its Price-To-Earnings Ratio (23.2x) compared to the peer average (38.7x).
Price to Earnings Ratio vs Industry
How does EDENP's PE Ratio compare vs other companies in the GB Diversified Financial Industry?
| 1 Company | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
NBS Nationwide Building Society | 0.9x | n/a | US$1.52b |
| 1 Company | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: EDENP is expensive based on its Price-To-Earnings Ratio (23.2x) compared to the UK Diversified Financial industry average (14.2x).
Price to Earnings Ratio vs Fair Ratio
What is EDENP's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 23.2x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate EDENP's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €28.70 | €49.46 +72.4% | 21.3% | €68.00 | €31.80 | n/a | 16 |
| Nov ’25 | €29.72 | €49.46 +66.4% | 21.3% | €68.00 | €31.80 | n/a | 16 |
| Oct ’25 | €34.73 | €57.64 +66.0% | 18.0% | €76.00 | €31.80 | n/a | 16 |
| Sep ’25 | €38.42 | €58.92 +53.4% | 17.4% | €76.00 | €33.20 | n/a | 16 |
| Aug ’25 | €37.47 | €58.92 +57.2% | 17.4% | €76.00 | €33.20 | n/a | 16 |
| Jul ’25 | €40.02 | €61.92 +54.7% | 13.3% | €76.00 | €38.60 | n/a | 17 |
| Jun ’25 | €43.43 | €62.71 +44.4% | 13.1% | €76.00 | €40.00 | n/a | 17 |
| May ’25 | n/a | €63.18 0% | 13.1% | €76.00 | €40.00 | n/a | 17 |
| Apr ’25 | €49.67 | €65.19 +31.3% | 8.2% | €76.00 | €55.00 | n/a | 16 |
| Mar ’25 | €46.52 | €66.51 +43.0% | 7.9% | €76.00 | €55.00 | n/a | 16 |
| Feb ’25 | n/a | €67.09 0% | 8.6% | €78.00 | €58.00 | n/a | 15 |
| Jan ’25 | n/a | €66.57 0% | 8.8% | €78.00 | €55.00 | n/a | 15 |
| Dec ’24 | n/a | €66.43 0% | 8.4% | €78.00 | €55.00 | n/a | 15 |
| Nov ’24 | €49.71 | €65.96 +32.7% | 7.5% | €72.50 | €55.00 | €29.72 | 14 |
| Oct ’24 | €59.49 | €67.58 +13.6% | 4.6% | €72.50 | €61.00 | €34.73 | 13 |
| Sep ’24 | €58.88 | €67.32 +14.3% | 4.6% | €72.50 | €61.00 | €38.42 | 14 |
| Aug ’24 | €59.08 | €66.96 +13.3% | 4.6% | €72.50 | €61.00 | €37.47 | 13 |
| Jul ’24 | €60.72 | €65.93 +8.6% | 4.5% | €69.00 | €60.00 | €40.02 | 13 |
| Jun ’24 | €60.98 | €65.86 +8.0% | 4.3% | €69.00 | €60.00 | €43.43 | 14 |
| May ’24 | €58.66 | €63.03 +7.4% | 6.9% | €68.00 | €50.00 | n/a | 14 |
| Apr ’24 | €54.90 | €61.06 +11.2% | 6.9% | €67.00 | €50.00 | €49.67 | 14 |
| Mar ’24 | €53.24 | €60.45 +13.5% | 7.0% | €67.00 | €50.00 | €46.52 | 15 |
| Feb ’24 | €50.01 | €58.04 +16.1% | 5.8% | €62.00 | €50.00 | n/a | 15 |
| Jan ’24 | €51.14 | €56.91 +11.3% | 8.9% | €63.00 | €42.00 | n/a | 16 |
| Dec ’23 | €52.82 | €56.66 +7.3% | 8.5% | €62.00 | €42.00 | n/a | 16 |
| Nov ’23 | €51.90 | €56.41 +8.7% | 8.3% | €62.00 | €42.00 | €49.71 | 16 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
Exor
€20.3b
Engages in the luxury goods, automotive, agricultural and construction equipment, commercial vehicles, and professional football businesses worldwide.
0RKY
€94.00
7D
-1.7%
1Y
8.5%
BFF Bank
€1.7b
Provides financial services to suppliers of the national health system and public administration sector in Italy, Croatia, the Czech Republic, France, Greece, Poland, Portugal, the Slovak Republic, and Spain.
0RON
€8.82
7D
1.3%
1Y
-10.9%
Man Group
UK£2.4b
Man Group Limited is a publicly owned investment manager.
EMGL
UK£2.11
7D
2.6%
1Y
-3.4%